Clinical Trial Update: Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing monthly versus daily buprenorphine formulations for treatment of moderate to severe opioid use disorder is ongoing with status unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Royal Victoria Hospital, Canada | Conditions: Moderate to Severe Opioid Use Disorder | Phase 4 | Status: UNKNOWN